Dear Reader,

I hope this email finds you well. I'm thrilled to share an exciting update regarding Citius Pharmaceuticals (NASDAQ: CTXR) that's sure to pique your interest.

Today, CTXR experienced an early run, soaring to an impressive high of $1.04, marking a remarkable milestone in its journey. It's currently trading in the mid .80's… Could the surge to $1.00 be possible?

Despite the fluctuations, the underlying potential of Citius Pharmaceuticals remains robust. The recent surge underscores the confidence researchers have in CTXR's innovative pipeline and clinical developments, affirming its position as a formidable player in the pharmaceutical industry.

I encourage you to seize this opp and delve deeper into Citius Pharmaceuticals (NASDAQ: CTXR). With each milestone achieved, CTXR continues to redefine possibilities in healthcare, offering a compelling journey of discovery and growth.

Whether you're a seasoned researcher or someone exploring new opp's, CTXR promises an exciting ride filled with potential. Don't miss out on this chance to be part of something extraordinary.

Add Citius Pharmaceuticals (NASDAQ: CTXR) to your watchlist now and stay tuned for more updates!

Warm regards,

Max Masters

Co-founder, Market Tips Newsletter

Data is provided from third-party sources and Market Tips is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized fin.ancial advice, are not finan.cial advisors, and our opinions are not suitable for all in.vest.ors. Please review our full disc.laim.er here. 

Pursuant to an agreement, Momentum Media LLC has been hired for a period beginning on 04/17/2024 and ending on 04/18/2024 to publicly disseminate information about (CTXR:US) via digital communications. We have been paid forty two thousand five hundred dollars USD. We own zero shares of (CTXR:US)